JESSIE CIROLIA: Open Payments
NPI 1548503105 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,996 in 55 payments from 18 companies in 2025. Trend: 2023 $1,008 · 2024 $1,667 · 2025 $1,996
Food & beverage: $1,996
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $661 |
| Amgen Inc. | 5 | $297 |
| ABBVIE INC. | 6 | $294 |
| Neurocrine BioSciences, Inc. | 2 | $155 |
| Corcept Therapeutics | 1 | $126 |
| Novo Nordisk Inc | 3 | $76 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| PFIZER INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
Products named: Auvelity, REPATHA, VRAYLAR, INGREZZA, QULIPTA, Korlym, Ozempic, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
